TA
NEO icon

Tiedemann Advisors’s NeoGenomics NEO Stock Holding History

Tiedemann Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,750
Closed -$236K – 302
2017
Q3 		$236K Buy
+28,750
New +$280K 0.02% 309
2017
Q1 		– Sell
-33,685
Closed -$289K – 414
2016
Q4 		$289K Buy
+33,685
New +$289K 0.03% 268

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Tiedemann Advisors's NEO Position: Q4 2017 in Review

Tiedemann Advisors sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 28,750 shares — an estimated $236K sold.

Tiedemann Advisors first reported a position in NEO in Q4 2016 and held it in 2 quarters. The position peaked at $289K in Q4 2016. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

  • Tiedemann Advisors reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
  • Tiedemann Advisors sold 28,750 NeoGenomics shares in Q4 2017, an estimated $236K.
  • Tiedemann Advisors first reported a position in NeoGenomics in Q4 2016 and held it in 2 quarters.
  • Tiedemann Advisors's NeoGenomics position peaked at $289K in Q4 2016.
  • 132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on Tiedemann Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.